- Home
- CVM vs ICCM Comparison
CVM vs ICCM Comparison
Compare CVM & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVM
- ICCM
- Stock Information
- Founded
- CVM 1983
- ICCM 2006
- Country
- CVM United States
- ICCM Israel
- Employees
- CVM N/A
- ICCM N/A
- Industry
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- ICCM
- Sector
- CVM Health Care
- ICCM
- Exchange
- CVM Nasdaq
- ICCM Nasdaq
- Market Cap
- CVM 53.1M
- ICCM 49.1M
- IPO Year
- CVM 1987
- ICCM N/A
- Fundamental
- Price
- CVM $6.71
- ICCM $0.71
- Analyst Decision
- CVM
- ICCM Strong Buy
- Analyst Count
- CVM 0
- ICCM 1
- Target Price
- CVM N/A
- ICCM $2.50
- AVG Volume (30 Days)
- CVM 91.8K
- ICCM 463.0K
- Earning Date
- CVM 08-14-2025
- ICCM 11-19-2025
- Dividend Yield
- CVM N/A
- ICCM N/A
- EPS Growth
- CVM N/A
- ICCM N/A
- EPS
- CVM N/A
- ICCM N/A
- Revenue
- CVM N/A
- ICCM $2,787,000.00
- Revenue This Year
- CVM N/A
- ICCM $2.92
- Revenue Next Year
- CVM N/A
- ICCM $57.81
- P/E Ratio
- CVM N/A
- ICCM N/A
- Revenue Growth
- CVM N/A
- ICCM N/A
- 52 Week Low
- CVM $1.98
- ICCM $0.56
- 52 Week High
- CVM $32.70
- ICCM $1.66
- Technical
- Relative Strength Index (RSI)
- CVM 35.37
- ICCM 36.88
- Support Level
- CVM $6.50
- ICCM $0.66
- Resistance Level
- CVM $7.36
- ICCM $0.72
- Average True Range (ATR)
- CVM 0.63
- ICCM 0.04
- MACD
- CVM -0.06
- ICCM 0.01
- Stochastic Oscillator
- CVM 18.32
- ICCM 41.49
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.